PulseAugur
EN
LIVE 14:17:40

Health tech firms Commure and Athelas face scrutiny over AI software performance · 2 sources tracked

STAT News has published an investigation into Commure and Athelas, two health tech companies backed by General Catalyst and valued at a combined $7 billion. The report highlights a stark contrast in customer experiences, with some users describing the AI revenue cycle software as "horrible" and reporting significant financial losses, while others praise it as "magic." The investigation also uncovered that some customers have Athelas email addresses and contractual clauses requiring them to refer new business, though the company claims these clauses were not enforced. AI

IMPACT Highlights potential risks and disparities in AI adoption within the healthcare revenue cycle management sector.

RANK_REASON Investigative report on the performance and customer experiences of AI software from health tech companies.

Read on Mastodon — sigmoid.social →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

Health tech firms Commure and Athelas face scrutiny over AI software performance · 2 sources tracked

COVERAGE [2]

  1. Mastodon — sigmoid.social TIER_1 English(EN) · [email protected] ·

    As our reporting shows, some of those happy customers have Athelas email addresses and are on the company Slack, or have stipulations written into their contrac

    As our reporting shows, some of those happy customers have Athelas email addresses and are on the company Slack, or have stipulations written into their contracts that say they have to refer new customers to the company -- a clause which the company says was never implemented. Bu…

  2. Mastodon — sigmoid.social TIER_1 English(EN) · [email protected] ·

    Today we published our months-long investigation into Commure (and Athelas), the General Catalyst-backed health tech company valued at a total of $7 billion. Wh

    Today we published our months-long investigation into Commure (and Athelas), the General Catalyst-backed health tech company valued at a total of $7 billion. Why do some Commure/Athelas customers call its AI revenue cycle software "horrible" and say they've lost over a million do…